Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Författare

  • Bhairavi Swaminathan
  • Guðmar Thorleifsson
  • Magnus Jöud
  • Mina Ali
  • Ellinor Johnsson
  • Ram Ajore
  • Patrick Sulem
  • Britt-Marie Halvarsson
  • Guðmundur Eyjolfsson
  • Vilhelmina Haraldsdottir
  • Christina Hultman
  • Erik Ingelsson
  • Sigurður Y Kristinsson
  • Anna K Kähler
  • Stig Lenhoff
  • Gisli Masson
  • Ulf-Henrik Mellqvist
  • Robert Månsson
  • Sven Nelander
  • Isleifur Olafsson
  • Olof Sigurðardottir
  • Hlif Steingrimsdóttir
  • Annette Vangsted
  • Ulla Vogel
  • Anders Waage
  • Hareth Nahi
  • Daniel F Gudbjartsson
  • Thorunn Rafnar
  • Ingemar Turesson
  • Urban Gullberg
  • Kári Stefánsson
  • Markus Hansson
  • Unnur Thorsteinsdóttir
  • Björn Nilsson

Summary, in English

Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells. While first-degree relatives of patients with MM show an increased risk of MM, the genetic basis of inherited MM susceptibility is incompletely understood. Here we report a genome-wide association study in the Nordic region identifying a novel MM risk locus at ELL2 (rs56219066T; odds ratio (OR)=1.25; P=9.6 × 10(-10)). This gene encodes a stoichiometrically limiting component of the super-elongation complex that drives secretory-specific immunoglobulin mRNA production and transcriptional regulation in plasma cells. We find that the MM risk allele harbours a Thr298Ala missense variant in an ELL2 domain required for transcription elongation. Consistent with a hypomorphic effect, we find that the MM risk allele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (P=8.6 × 10(-9) and P=6.4 × 10(-3), respectively) and, potentially, with an increased risk of bacterial meningitis (OR=1.30; P=0.0024).

Avdelning/ar

Publiceringsår

2015

Språk

Engelska

Sidor

1-8

Publikation/Tidskrift/Serie

Nature Communications

Volym

6

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Hematology

Status

Published

Projekt

  • Genetic predisposition for multiple myeloma

Forskningsgrupp

  • Hematogenomics
  • Myeloma research group

ISBN/ISSN/Övrigt

  • ISSN: 2041-1723